Latest Health News

Tag: obesity-drug

  • Zafgen to scrap lead obesity drug, shares slide

    —

    by

    contributor
    in

    (Reuters) – Zafgen Inc said it was suspending the development of its lead obesity drug, beloranib, more than six months after the U.S. Food and Drug Administration asked the company to halt all tests on the drug following the death of two patients. Zafgen’s shares tumbled more than 40 percent in extended trading on Tuesday…